← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Winsantor, Inc.
San Diego, CA
$12,015,011
Total funding
8
Grants
Funding over time
peak $2.4M · FY2014–22$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,015,011 · 8
By mechanism
R44$7,332,903 · 2
R42$1,997,420 · 1
R41$1,464,462 · 3
SB1$1,220,226 · 2
Investigators at Winsantor, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Pirenzepine for CIPN$1,373,465
R42 · FY2019 · CA
Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy$1,101,366
R44 · FY2021 · CA
Regeneration of Epidermal Nerves in Human Diabetic Neuropathy$1,000,000
R44 · FY2019 · DK
Regeneration of Epidermal Nerves in Human Diabetic Neuropathy$995,582
R44 · FY2020 · DK
Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy$986,763
R44 · FY2015 · DK
Regeneration of Epidermal Nerves in Human Diabetic Neuropathy$985,495
R44 · FY2021 · DK
Assessment of chronic toxicity to support the use of topical pirenzepine for treating diabetic neuropathy$970,226
SB1 · FY2017 · DK
Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy$898,634
R44 · FY2022 · CA
Development of a topical fixed-dose combination drug for peripheral neuropathic pain.$699,491
R41 · FY2020 · NS
Development of Pirenzepine for CIPN$623,955
R42 · FY2018 · CA
Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy$591,725
R44 · FY2016 · DK
Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy$473,338
R44 · FY2014 · DK
Development of Pirenzepine for HIV-SN$466,421
R41 · FY2017 · NS
Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy$300,000
R44 · FY2016 · DK
Development of Pirenzepine for CIPN$298,550
R41 · FY2017 · CA
Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN.$250,000
SB1 · FY2020 · CA